News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Week in Review: Hainan Haiyo Invests $20 Million In VC Fund


3/17/2014 8:55:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

March 15, 2015 --Hainan Haiyao of China will take a 49% position in a $41 million pharma-focused China venture capital JV with a $20 million investment; Clinipace Worldwide, a US-based CRO, acquired Choice Pharma, which offers pan-Asian clinical CRO services; Applikon Biotech will officially open its new bioreactor manufacturing facility in Guangzhou; TaiGen Biotech received TaiWan marketing approval for Taigexyn®, a novel antibiotic aimed at community-acquired pneumonia; Roche has been donating 8 free vials of cancer drug Herceptin for every six vials bought by Jiangsu province, and Jiangsu then pays two-thirds of the remaining cost, making the drug more affordable; WuXi PharmaTech purchased a state-of-the-art Illumina genomic sequencer to produce $1,000 human genomes; and WuXi will also collaborate with Pacific Biomarkers, offering PBI’s biomarker assays to WuXi's clinical-stage clients. More details….

Stock Symbols: (SHE: 000566) (TWO: 4157) (SIX: ROG) (NYSE: WX) (NSDQ: ILMN)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES